

1,401,944 filings since 2004 · latest accepted Nov 4, 2026, 6:08 AM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Oct 22, 2026 accepted 11:31 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Aug 11, 2026 accepted 9:19 PM ET | ELOXEloxx Pharmaceuticals, Inc. | Earnings release |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Jun 1, 2026 accepted 11:00 AM ET | ELOXEloxx Pharmaceuticals, Inc. | 3.02Unregistered equity sale3.03Holder rights modified5.02Officer / director change5.03Bylaws / fiscal year | DocumentSEC ↗ |
May 1, 2026 accepted 8:05 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
Aug 12, 2025 accepted 9:22 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Oct 17, 2024 accepted 8:01 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Jul 16, 2024 accepted 9:23 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Mar 29, 2024 accepted 8:11 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Mar 14, 2024 accepted 8:30 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Jan 9, 2024 accepted 10:10 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Dec 28, 2023 accepted 9:11 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Dec 15, 2023 accepted 9:10 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Nov 13, 2023 accepted 9:58 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Oct 16, 2023 accepted 9:26 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Sep 20, 2023 accepted 8:05 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Sep 18, 2023 accepted 12:05 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 8.01Other events | DocumentSEC ↗ |
Sep 15, 2023 accepted 9:15 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Sep 7, 2023 accepted 2:14 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 8.01Other events | DocumentSEC ↗ |
Aug 29, 2023 accepted 8:32 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 21, 2023 accepted 8:50 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Aug 14, 2023 accepted 3:56 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.01Acquisition / disposition | DocumentSEC ↗ |
Aug 3, 2023 accepted 8:01 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 8.01Other events | DocumentSEC ↗ |
Jul 13, 2023 accepted 12:43 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 8.01Other events | DocumentSEC ↗ |
Jun 23, 2023 accepted 10:32 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
Jun 15, 2023 accepted 1:15 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 8.01Other events | DocumentSEC ↗ |
Jun 7, 2023 accepted 12:32 AM ET | ELOXEloxx Pharmaceuticals, Inc. | 8.01Other events | DocumentSEC ↗ |
May 24, 2023 accepted 12:07 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement1.02Agreement terminated8.01Other events | DocumentSEC ↗ |
May 16, 2023 accepted 10:01 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Apr 14, 2023 accepted 8:06 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Apr 3, 2023 accepted 1:27 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Mar 9, 2023 accepted 9:12 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |
Dec 1, 2022 accepted 10:04 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 3.03Holder rights modified5.03Bylaws / fiscal year5.07Shareholder vote8.01Other events | DocumentSEC ↗ |
Nov 14, 2022 accepted 9:09 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Oct 14, 2022 accepted 8:31 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Sep 15, 2022 accepted 12:07 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Aug 15, 2022 accepted 8:18 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jul 15, 2022 accepted 11:06 AM ET | ELOXEloxx Pharmaceuticals, Inc. | 4.01Auditor change | DocumentSEC ↗ |
Jul 5, 2022 accepted 12:28 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change7.01Reg FD disclosure | DocumentSEC ↗ |
Jun 16, 2022 accepted 8:10 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.07Shareholder vote | DocumentSEC ↗ |
May 10, 2022 accepted 9:28 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Apr 4, 2022 accepted 12:45 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jan 5, 2022 accepted 10:44 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 3.01Delisting notice | DocumentSEC ↗ |
Nov 17, 2021 accepted 12:41 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 7.01Reg FD disclosure8.01Other events | DocumentSEC ↗ |
Nov 9, 2021 accepted 1:03 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Oct 5, 2021 accepted 12:10 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement2.01Acquisition / disposition2.03New debt obligation | DocumentSEC ↗ |
Sep 30, 2021 accepted 12:52 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 1.01Material agreement8.01Other events | DocumentSEC ↗ |
Sep 13, 2021 accepted 8:07 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 7.01Reg FD disclosure | DocumentSEC ↗ |
Aug 20, 2021 accepted 8:02 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |
Aug 17, 2021 accepted 12:43 AM ET | ELOXEloxx Pharmaceuticals, Inc. | 2.02Earnings release | DocumentSEC ↗ |
Jul 16, 2021 accepted 8:24 PM ET | ELOXEloxx Pharmaceuticals, Inc. | 5.02Officer / director change | DocumentSEC ↗ |